Literature DB >> 28533056

White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Molly Braun1, Kumar Vaibhav2, Nancy M Saad3, Sumbul Fatima4, John R Vender1, Babak Baban5, Md Nasrul Hoda6, Krishnan M Dhandapani7.   

Abstract

Traumatic brain injury (TBI) is a leading cause of mortality and long-term morbidity worldwide. Despite decades of pre-clinical investigation, therapeutic strategies focused on acute neuroprotection failed to improve TBI outcomes. This lack of translational success has necessitated a reassessment of the optimal targets for intervention, including a heightened focus on secondary injury mechanisms. Chronic immune activation correlates with progressive neurodegeneration for decades after TBI; however, significant challenges remain in functionally and mechanistically defining immune activation after TBI. In this review, we explore the burgeoning evidence implicating the acute release of damage associated molecular patterns (DAMPs), such as adenosine 5'-triphosphate (ATP), high mobility group box protein 1 (HMGB1), S100 proteins, and hyaluronic acid in the initiation of progressive neurological injury, including white matter loss after TBI. The role that pattern recognition receptors, including toll-like receptor and purinergic receptors, play in progressive neurological injury after TBI is detailed. Finally, we provide support for the notion that resident and infiltrating macrophages are critical cellular targets linking acute DAMP release with adaptive immune responses and chronic injury after TBI. The therapeutic potential of targeting DAMPs and barriers to clinical translational, in the context of TBI patient management, are discussed.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HMGB1; Leukocyte; Lymphocyte; Macrophage; Microglia; Oligodendrocyte; S100; T-cell; Toll like receptor; White matter injury

Mesh:

Substances:

Year:  2017        PMID: 28533056      PMCID: PMC5653450          DOI: 10.1016/j.bbadis.2017.05.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  282 in total

1.  S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).

Authors:  Thiruvengadam Arumugam; Diane M Simeone; Ann Marie Schmidt; Craig D Logsdon
Journal:  J Biol Chem       Date:  2003-11-14       Impact factor: 5.157

2.  IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions.

Authors:  Jean-Pierre Allam; Yonggang Duan; Friedhelm Heinemann; Jochen Winter; Werner Götz; James Deschner; Matthias Wenghoefer; Thomas Bieber; Soren Jepsen; Natalija Novak
Journal:  J Clin Periodontol       Date:  2011-08-31       Impact factor: 8.728

3.  Antagonism of purinergic signalling improves recovery from traumatic brain injury.

Authors:  Anthony M Choo; William J Miller; Yung-Chia Chen; Philip Nibley; Tapan P Patel; Cezar Goletiani; Barclay Morrison; Melinda K Kutzing; Bonnie L Firestein; Jai-Yoon Sul; Philip G Haydon; David F Meaney
Journal:  Brain       Date:  2013-01-04       Impact factor: 13.501

Review 4.  Experimental models of traumatic brain injury: do we really need to build a better mousetrap?

Authors:  D M Morales; N Marklund; D Lebold; H J Thompson; A Pitkanen; W L Maxwell; L Longhi; H Laurer; M Maegele; E Neugebauer; D I Graham; N Stocchetti; T K McIntosh
Journal:  Neuroscience       Date:  2005-10-20       Impact factor: 3.590

5.  Evaluation of White Matter Injury Patterns Underlying Neuropsychiatric Symptoms after Mild Traumatic Brain Injury.

Authors:  Lea M Alhilali; Joseph A Delic; Serter Gumus; Saeed Fakhran
Journal:  Radiology       Date:  2015-06-16       Impact factor: 11.105

6.  Interactions between corticotropin-releasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders.

Authors:  A C E Linthorst
Journal:  Handb Exp Pharmacol       Date:  2005

Review 7.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

8.  Extracranial sources of S100B do not affect serum levels.

Authors:  Nancy Pham; Vincent Fazio; Luca Cucullo; Qingshan Teng; Peter Biberthaler; Jeffrey J Bazarian; Damir Janigro
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

9.  An organotypic slice culture model of chronic white matter injury with maturation arrest of oligodendrocyte progenitors.

Authors:  Justin M Dean; Art Riddle; Jennifer Maire; Kelly D Hansen; Marnie Preston; Anthony P Barnes; Larry S Sherman; Stephen A Back
Journal:  Mol Neurodegener       Date:  2011-07-05       Impact factor: 14.195

Review 10.  CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases.

Authors:  Zhuchi Tu; Weili Yang; Sen Yan; Xiangyu Guo; Xiao-Jiang Li
Journal:  Mol Neurodegener       Date:  2015-08-04       Impact factor: 14.195

View more
  27 in total

1.  Relative Deficiency of Plasma A Disintegrin and Metalloprotease with Thrombospondin Type 1 Repeats 13 Activity and Elevation of Human Neutrophil Peptides in Patients with Traumatic Brain Injury.

Authors:  Monisha A Kumar; Wenjing Cao; Huy P Pham; Dheeraj Raju; Kelsey Nawalinski; Eileen Maloney-Wilensky; James Schuster; X Long Zheng
Journal:  J Neurotrauma       Date:  2018-08-14       Impact factor: 5.269

2.  Immune and metabolic alterations following trauma and sepsis - An overview.

Authors:  Raghavan Raju
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-08-24       Impact factor: 5.187

3.  HMGB1-RAGE Signaling Plays a Role in Organic Dust-Induced Microglial Activation and Neuroinflammation.

Authors:  Nyzil Massey; Sreekanth Puttachary; Sanjana Mahadev Bhat; Anumantha G Kanthasamy; Chandrashekhar Charavaryamath
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

4.  High-Mobility Group Box 1 Neutralization Prevents Chronic Cerebral Hypoperfusion-Induced Optic Tract Injuries in the White Matter Associated with Down-regulation of Inflammatory Responses.

Authors:  Yue Hei; Xin Zhang; Rong Chen; Yuefei Zhou; Dakuan Gao; Weiping Liu
Journal:  Cell Mol Neurobiol       Date:  2019-06-13       Impact factor: 5.046

Review 5.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 6.  Innate immune responses to trauma.

Authors:  Markus Huber-Lang; John D Lambris; Peter A Ward
Journal:  Nat Immunol       Date:  2018-03-05       Impact factor: 25.606

7.  Induction of endothelial barrier dysfunction by serum factors in rats subjected to traumatic brain injury and hemorrhagic shock.

Authors:  Yunbo Ke; Julie L Proctor; Chenou Zhang; Juliana Medina; Catriona H T Miller; Junghyun Kim; Thomas E Grissom; Anna A Birukova; Gary M Fiskum; Konstantin G Birukov
Journal:  Physiol Rep       Date:  2022-07

Review 8.  Impact of pediatric traumatic brain injury on hippocampal neurogenesis.

Authors:  Mariam Rizk; Justin Vu; Zhi Zhang
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

Review 9.  The Role of HMGB1 in Traumatic Brain Injury-Bridging the Gap Between the Laboratory and Clinical Studies.

Authors:  S Manivannan; E Wales; M Zaben
Journal:  Curr Neurol Neurosci Rep       Date:  2021-12-06       Impact factor: 5.081

Review 10.  The Molecular Pathophysiology of Concussion.

Authors:  David R Howell; Julia Southard
Journal:  Clin Sports Med       Date:  2021-01       Impact factor: 2.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.